Hans van Houte insider trades

Open-market stock purchases and sales by Hans van Houte, Chief Financial Officer at Nurix Therapeutics, Inc, from SEC Form 4 filings since Feb 11, 2021.

Recent trades

DateStockTradeValue
Aug 4, 2026NRIX Nurix Therapeutics, IncSold$42.9K
Aug 4, 2026NRIX Nurix Therapeutics, IncSold$73.1K
Jul 30, 2026NRIX Nurix Therapeutics, IncSold$66.5K
Jul 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jul 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jul 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
May 5, 2026NRIX Nurix Therapeutics, IncSold$223K
May 5, 2026NRIX Nurix Therapeutics, IncSold$10K
Apr 30, 2026NRIX Nurix Therapeutics, IncSold$39.7K
Apr 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Apr 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Apr 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Feb 10, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Feb 10, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncSold$59.5K
Jan 30, 2026NRIX Nurix Therapeutics, IncSold$1.3K
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Jan 30, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Nov 3, 2025NRIX Nurix Therapeutics, IncSold$78.9K
Oct 30, 2025NRIX Nurix Therapeutics, IncBought (not open market)—
Oct 30, 2025NRIX Nurix Therapeutics, IncSold$40.1K
Oct 30, 2025NRIX Nurix Therapeutics, IncBought (not open market)—
Oct 30, 2025NRIX Nurix Therapeutics, IncBought (not open market)—

Companies traded

  • NRIX Nurix Therapeutics, Inc: 45 sales, last Aug 4, 2026

Get free alerts when Hans van Houte files a new trade →